CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

Ozempic without the side effects? New drug touted as weight loss game changer By Diana Bruk Published June 26, 2025, 5:36 p.m. ET ...

Please note that Novo Nordisk’s once-weekly subcutaneous diabetes injection, Ozempic, is already approved in 0.25 mg, 0.5 mg, 1 mg and 2 mg doses for treating type II diabetes (T2D) mellitus in adults ...

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

(Reuters) -Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a condition called peripheral artery disease. The company ...

This situation is no different.” A hidden danger The trend also poses a serious risk of infection. “GLP-1 pens are designed to be used as a sealed system,” Snyder said.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

The initial shipment of Johnnie Walker Blue Guam Special Edition 2025 has arrived as part of a limited quantity planned for production this year, according to Island Beverage Distributors.

Schools combat AI cheating with pen and paper because 89% of students use tools like ChatGPT for coursework, forcing educators to rethink assessment methods and teach responsible AI use.

Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed ...